Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

SIG-1451 could be a promising new treatment for atopic dermatitis.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Sulfur-35 can be used to track hair growth and past exposure.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Cepharanthine shows promise as a COVID-19 treatment.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

If someone has scaly skin, muscle stiffness, and intellectual disability, doctors should consider Sjogren-Larsson Syndrome, but other conditions if more symptoms are present.

Selenium-75 stays in dog hair for up to 316 days.

Quercetin may help improve skin conditions in cats with Feline Atopic Skin Syndrome.

Finasteride almost fully depletes allopregnanolone in rat brains and enhances 20α-DHP, but doesn't change 3α-DHP levels.

Researchers found a non-functional sheep keratin gene due to mutations.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

A new genetic change in the DSC3 gene is linked to a rare condition causing hair loss and skin blisters in a child.

Several companies launched new hair care ingredients in 2011 to improve conditioning, color retention, combability, and heat protection.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

Targeting the Smoothened receptor shows promise for treating certain cancers.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

P-3074 effectively blocks scalp DHT better than oral finasteride.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

5α-reductases increase epitestosterone's effect on androgen receptors.

ALRN-6924 may prevent hair loss caused by chemotherapy.